Awards & Grant

• 5 grants received during the scholar training;
• The poster “Characterization of a panel of cell lines and tissue with a new anti hTERT monoclonal antibody,” (S. Bravaccini et al) presented at the AACR, USA, won the “Geron Corporation” award Nov 2004;
• The project “Study of new predictive biomarkers for adjuvant therapy in highly proliferating breast tumors (Studio IBIS3)” S Bravaccini, et al won IOR (Istituto Oncologico Romagnolo) award 2009;
• The oral presentation “Non Invasive, early diagnosis of superficial bladder cancer: urine cell free Dna integrity and cytology” at the 22° Nazional Congress in Urology. Bologna, Italy WON THE Rocchetta award jun 2012;
• Grant of 10.000 euro obtained in 2010 by ANMIC (Associazione nazionale mutilati e invalidi civili) to perform the study on the identification of new biological markers involved in the development of males’ breast cancer (PI Bravaccini S);
• OECI Meeting Bursary Award, Amsterdam, Holland 17 march 2016. 5X1000 Grant for the project on Nanostring “Study of Trastuzumab Resistance mechanisms in HER2 positive breast cancer“ 2018 (PI Bravaccini S);
• Charity Cosmoprof (Bologna, Italy) Grant 826.700 EURO) for the project “Study of Trastuzumab Resistance mechanisms in HER2 positive breast cancer“ 2018 (PI Bravaccini S);
• Donation of 10.000 euro on the project on the study of mechanisms of resistance to endocrine therapy in breast cancer patients 2018 (PI Bravaccini S). -Donation of 2.000 euro by GAPP association on the project on the Study of Trastuzumab Resistance mechanisms in HER2 positive breast cancer 2018 (PI Bravaccini S);
• Donation of 2.000 euro by GAPP association on the project on the Study of Trastuzumab Resistance mechanisms in HER2 positive breast cancer 2019 (PI Bravaccini S).